当前位置: X-MOL 学术Br. J. Cancer › 论文详情
Effective delivery of Complex Innovative Design (CID) cancer trials-A consensus statement.
British Journal of Cancer ( IF 5.791 ) Pub Date : 2020-01-06 , DOI: 10.1038/s41416-019-0653-9
Sarah P Blagden,Lucinda Billingham,Louise C Brown,Sean W Buckland,Alison M Cooper,Stephanie Ellis,Wendy Fisher,Helen Hughes,Debbie A Keatley,Francois M Maignen,Alex Morozov,Will Navaie,Sarah Pearson,Abeer Shaaban,Kirsty Wydenbach,Pamela R Kearns,

The traditional cancer drug development pathway is increasingly being superseded by trials that address multiple clinical questions. These are collectively termed Complex Innovative Design (CID) trials. CID trials not only assess the safety and toxicity of novel anticancer medicines but also their efficacy in biomarker-selected patients, specific cancer cohorts or in combination with other agents. They can be adapted to include new cohorts and test additional agents within a single protocol. Whilst CID trials can speed up the traditional route to drug licencing, they can be challenging to design, conduct and interpret. The Experimental Cancer Medicine Centres (ECMC) network, funded by the National Institute for Health Research (NIHR), Cancer Research UK (CRUK) and the Health Boards of Wales, Northern Ireland and Scotland, formed a working group with relevant stakeholders from clinical trials units, the pharmaceutical industry, funding bodies, regulators and patients to identify the main challenges of CID trials. The working group generated ten consensus recommendations. These aim to improve the conduct, quality and acceptability of oncology CID trials in clinical research and, importantly, to expedite the process by which effective treatments can reach cancer patients.
更新日期:2020-01-06

 

全部期刊列表>>
chemistry
物理学研究前沿热点精选期刊推荐
自然职位线上招聘会
欢迎报名注册2020量子在线大会
化学领域亟待解决的问题
材料学研究精选新
GIANT
ACS ES&T Engineering
ACS ES&T Water
ACS Publications填问卷
屿渡论文,编辑服务
阿拉丁试剂right
南昌大学
王辉
南方科技大学
彭小水
隐藏1h前已浏览文章
课题组网站
新版X-MOL期刊搜索和高级搜索功能介绍
ACS材料视界
天合科研
x-mol收录
赵延川
李霄羽
廖矿标
朱守非
试剂库存
down
wechat
bug